Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.

@article{Rothberg2003ManagementOI,
  title={Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.},
  author={Michael Bryan Rothberg and Sandra Bellantonio and David N. Rose},
  journal={Annals of internal medicine},
  year={2003},
  volume={139 5 Pt 1},
  pages={
          321-9
        }
}
Context Drugs to treat influenza are cost-effective in adults younger than 65 years of age, but the cost-effectiveness of these drugs for people older than 65 years is unknown. Contribution For unvaccinated persons older than 65 years of age with influenza-like illness, empirical treatment with amantadine cost $1129 per quality-adjusted life-year (QALY), treatment with oseltamivir after rapid diagnostic testing cost $5025 per QALY, and empirical treatment with oseltamivir cost $10 296 per QALY… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 39 REFERENCES

of Labor, Bureau of Labor Statistics

  • U. S. Departmen
  • Consumer Price Index—All Urban Consumers…
  • 2002
2 Excerpts

Similar Papers

Loading similar papers…